Literature DB >> 7144866

Magnetic-susceptibility measurement of human iron stores.

G M Brittenham, D E Farrell, J W Harris, E S Feldman, E H Danish, W A Muir, J H Tripp, E M Bellon.   

Abstract

We made direct noninvasive magnetic measurements of hepatic iron stores with a specially designed superconducting quantum-interference-device (SQUID) susceptometer in 20 normal subjects and in 110 patients with liver disease, iron deficiency, hereditary hemochromatosis, or transfusional iron overload. Magnetic in vivo measurements of liver non-heme iron were closely correlated with chemical in vitro measurements in liver-biopsy specimens (r = 0.98, P less than 10(-5) up to 115 mumol per gram of liver tissue (wet weight) or more. Magnetically determined storage-iron concentrations were below 6.0 mumol per gram in iron-deficient patients and normal men and premenopausal women, but they were raised (9.7 to 31.4 mumol) in 12 of 67 patients with liver disease and were greatly increased (22.9 to 117.7 mumol) in patients with untreated hereditary hemochromatosis or transfusional iron overload. Magnetic measurements of iron stores provide a new quantitative technique for early detection of hereditary hemochromatosis and for rapid evaluation of treatment regimens for transfusional iron overload.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7144866     DOI: 10.1056/NEJM198212303072703

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  60 in total

1.  Room-temperature susceptometry predicts biopsy-determined hepatic iron in patients with elevated serum ferritin.

Authors:  Bryan D Maliken; William F Avrin; James E Nelson; Jody Mooney; Sankaran Kumar; Kris V Kowdley
Journal:  Ann Hepatol       Date:  2012 Jan-Feb       Impact factor: 2.400

Review 2.  Optimizing therapy for iron overload in the myelodysplastic syndromes: recent developments.

Authors:  Heather A Leitch
Journal:  Drugs       Date:  2011-01-22       Impact factor: 9.546

3.  Magnetite biomineralization in the human brain.

Authors:  J L Kirschvink; A Kobayashi-Kirschvink; B J Woodford
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

4.  MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients.

Authors:  John C Wood; Cathleen Enriquez; Nilesh Ghugre; J Michael Tyzka; Susan Carson; Marvin D Nelson; Thomas D Coates
Journal:  Blood       Date:  2005-04-28       Impact factor: 22.113

5.  A biomagnetic system for in vivo cancer imaging.

Authors:  E R Flynn; H C Bryant
Journal:  Phys Med Biol       Date:  2005-03-02       Impact factor: 3.609

6.  Diagnosis and management of transfusion iron overload: the role of imaging.

Authors:  John C Wood
Journal:  Am J Hematol       Date:  2007-12       Impact factor: 10.047

Review 7.  Magnetic resonance imaging measurement of iron overload.

Authors:  John C Wood
Journal:  Curr Opin Hematol       Date:  2007-05       Impact factor: 3.284

Review 8.  Quantification of liver iron with MRI: state of the art and remaining challenges.

Authors:  Diego Hernando; Yakir S Levin; Claude B Sirlin; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2014-03-03       Impact factor: 4.813

Review 9.  Estimating tissue iron burden: current status and future prospects.

Authors:  John C Wood
Journal:  Br J Haematol       Date:  2015-03-12       Impact factor: 6.998

10.  Iron chelation therapy in aceruloplasminaemia: study of a patient with a novel missense mutation.

Authors:  R Mariani; C Arosio; S Pelucchi; M Grisoli; A Piga; P Trombini; A Piperno
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.